Soleno Therapeutics (SLNO) EPS (Basic) (2016 - 2017)
Historic EPS (Basic) for Soleno Therapeutics (SLNO) over the last 5 years, with Q4 2017 value amounting to -$0.4.
- Soleno Therapeutics' EPS (Basic) rose 7989.95% to -$0.4 in Q4 2017 from the same period last year, while for Sep 2018 it was -$0.03, marking a year-over-year increase of 9924.68%. This contributed to the annual value of -$4.38 for FY2024, which is 8559.32% down from last year.
- As of Q4 2017, Soleno Therapeutics' EPS (Basic) stood at -$0.4, which was up 7989.95% from -$0.39 recorded in Q3 2017.
- In the past 5 years, Soleno Therapeutics' EPS (Basic) registered a high of $0.25 during Q2 2015, and its lowest value of -$220.0 during Q1 2016.
- Its 5-year average for EPS (Basic) is -$13.67, with a median of -$1.22 in 2014.
- Per our database at Business Quant, Soleno Therapeutics' EPS (Basic) surged by 10479.85% in 2015 and then plummeted by 1307365.27% in 2016.
- Quarter analysis of 5 years shows Soleno Therapeutics' EPS (Basic) stood at -$1.62 in 2013, then tumbled by 102.13% to -$3.28 in 2014, then soared by 90.8% to -$0.3 in 2015, then crashed by 559.42% to -$1.99 in 2016, then skyrocketed by 79.9% to -$0.4 in 2017.
- Its last three reported values are -$0.4 in Q4 2017, -$0.39 for Q3 2017, and -$0.42 during Q2 2017.